These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10654330)

  • 21. Desmopressin tablet treatment in nocturnal enuresis.
    Stenberg A; Läckgren G
    Scand J Urol Nephrol Suppl; 1995; 173():95-9. PubMed ID: 8719577
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis.
    Rushton HG; Belman AB; Zaontz MR; Skoog SJ; Sihelnik S
    J Urol; 1996 Aug; 156(2 Pt 2):651-5. PubMed ID: 8683752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmopressin in a long-term treatment of children with primary nocturnal enuresis--a symptomatic therapy?
    Snajderová M; Lehotská V; Kernová T; Kocnarová N; Archmanová E; Janda P; Lánská V
    Eur J Pediatr; 2001 Mar; 160(3):197-8. PubMed ID: 11277386
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyponatremic seizure in a child using desmopressin for nocturnal enuresis.
    Donoghue MB; Latimer ME; Pillsbury HL; Hertzog JH
    Arch Pediatr Adolesc Med; 1998 Mar; 152(3):290-2. PubMed ID: 9529469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No relationship between family history of enuresis and response to desmopressin.
    Schaumburg HL; Rittig S; Djurhuus JC
    J Urol; 2001 Dec; 166(6):2435-7. PubMed ID: 11696806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desmopressin resistant enuresis: pathogenetic and therapeutic considerations.
    Nevéus T; Läckgren G; Tuvemo T; Olsson U; Stenberg A
    J Urol; 1999 Dec; 162(6):2136-40. PubMed ID: 10569604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of renal morphology and function in children with nocturnal enuresis. Relationship with sensitivity or resistance to desmopressin].
    Marrero Pérez CL; García Nieto V; Luis Yanes MI
    An Pediatr (Barc); 2005 Dec; 63(6):475-9. PubMed ID: 16324611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desmopressin for nocturnal incontinence in the spina bifida population.
    Horowitz M; Combs AJ; Gerdes D
    J Urol; 1997 Dec; 158(6):2267-8. PubMed ID: 9366373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of primary monosymptomatic nocturnal enuresis with desmopressin: predictive factors.
    Kruse S; Hellström AL; Hanson E; Hjälmås K; Sillén U;
    BJU Int; 2001 Oct; 88(6):572-6. PubMed ID: 11678753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis.
    Radmayr C; Schlager A; Studen M; Bartsch G
    Eur Urol; 2001 Aug; 40(2):201-5. PubMed ID: 11528199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with the long-term use of desmopressin for nocturnal enuresis in children and adolescents.
    van Kerrebroeck PE
    BJU Int; 2002 Mar; 89(4):420-5. PubMed ID: 11872036
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of indomethacin on desmopressin resistant nocturnal polyuria and nocturnal enuresis.
    Kamperis K; Rittig S; Bower WF; Djurhuus JC
    J Urol; 2012 Nov; 188(5):1915-22. PubMed ID: 22999686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound bladder measurements in patients with primary nocturnal enuresis: a urodynamic and treatment outcome correlation.
    Yeung CK; Sreedhar B; Leung VT; Metreweli C
    J Urol; 2004 Jun; 171(6 Pt 2):2589-94. PubMed ID: 15118426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional bladder capacity as predictor of response to desmopressin and retention control training in monosymptomatic nocturnal enuresis.
    Hamano S; Yamanishi T; Igarashi T; Ito H; Murakami S
    Eur Urol; 2000 Jun; 37(6):718-22. PubMed ID: 10828674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diuretic treatment of nocturnal enuresis: preliminary results of an open pilot study.
    Nevéus T; Johansson E; Hansson S
    J Urol; 2004 Jun; 171(6 Pt 2):2584-5. PubMed ID: 15118424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desmopressin versus indomethacin treatment in primary nocturnal enuresis and the role of prostaglandins.
    Sener F; Hasanoğlu E; Söylemezoğlu O
    Urology; 1998 Nov; 52(5):878-81. PubMed ID: 9801119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between desmopressin treatment and voiding pattern in children.
    Hvistendahl GM; Rawashdeh YF; Kamperis K; Hansen MN; Rittig S; Djurhuus JC
    BJU Int; 2002 Jun; 89(9):917-22. PubMed ID: 12010240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
    De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of urodynamics in treatment of primary nocturnal enuresis persisting into adulthood.
    Yucel S; Kutlu O; Kukul E; Baykara M
    Urology; 2004 Nov; 64(5):1020-5; discussion 1025. PubMed ID: 15533498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.